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Macular hole (MH) in myopic eyes is a disease arising from complex tractional forces exerted by vitreomacular interface,
epiretinal tissue, and progressive scleral ectasia of the posterior ocular globe wall. 'is retinal disease requires vitreoretinal
treatment for its repair, and the surgical intervention remains a challenge also for experienced surgeons. 'e aim of this review is
to describe the current knowledge regarding the pathogenesis of MH in myopic eyes and to detail novel surgical techniques and
technological advancements in its surgical management.
1. Introduction
Idiopathic macular hole (MH) is an important cause of central
visual loss [1] characterized by a round full-thickness defect in
the center of the macular area involving the anatomical fovea
[2, 3]. 'e estimated prevalence in the general population is
approximately 3.3 per 1000 people [4, 5], with a cumulative
incidence of MH formation of 41.1 cases per 100 000 person/
years [6]. 'is incidence increases with age, and the disease
usually aﬀects individuals in their sixth or seventh decade of
life [7]. Females have a 64% increased risk of being diagnosed
with MH when compared with males [6]. MH is a common
complication in pathological myopic eyes with an axial length
greater than 26.5mm and/or a refraction greater than −6.00
diopters [8, 9], and a prevalence of 8.4% has been reported
[10].'e incidence of myopicMH is greater in Asian ethnicity
compared to Caucasian or black individuals due to the high
prevalence ofmyopic refractive defect in Asian population [6].
For many years, MH was considered an untreatable
disease resulting in irreversible vision loss. In the early 90s,
new surgical strategies to treat this anatomical macular
defect in order to improve the visual acuity were described.
'e surgical procedure consisted of three-port pars plana
vitrectomy (PPV) with posterior hyaloid removal in com-
bination with intraocular gas tamponade to allow the
ﬂattening and the repositioning of MH edges [11, 12]. A
remarkable success rate and a clear beneﬁt from this type of
surgical management were reported [13–16].
Although pars plana vitrectomy with posterior hyaloid
removal, internal limiting membrane (ILM) peeling, long-
acting gas tamponade, and face-down positioning is still the
gold standard for a successful closure of idiopathic MH, the
treatment of large, persistent, or myopic MH remains a
challenge [17–19]. Nowadays, several methods have been
proposed to allow high rate of success, particularly for the
abovementioned MH such as the inverted ILM ﬂap [20],
inverted ILM ﬂap insertion [21] with or without blood
coverage of the hole [22], temporal or superior single-layer
inverted ILMﬂap [23, 24], free ILM insertion [25], and double
[26] or multiple free ILM ﬂap insertion [16] into the MH.
'e purpose of this review is to describe the current
knowledge regarding the pathogenesis ofMH inmyopic eyes
and to detail novel surgical techniques and technological
advancements in the surgical management of this retinal
disease.
2. Pathogenesis
'e biomicroscopic identiﬁcation of MH in highly myopic
eyes may be diﬃcult due to several factors such as the typical
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low contrast between the anatomical foveal defect and the
retinal pigmented epithelium (RPE), the chorioretinal at-
rophy, or the presence of a deep posterior staphyloma [27].
'e introduction of optical coherence tomography
(OCT), which provides an in vivo analysis of the relationship
between the macula and the vitreous, has allowed identifying
the perifoveal vitreous changes that may lead to MH for-
mation. In particular, OCT is able to detect the localized
adhesion between vitreous cortex and fovea, the incomplete
posterior vitreous detachment associated with a full-
thickness MH [28–30] and the ILM contraction that cre-
ates a tangential traction responsible of MH enlargement
[19].
'e anteroposterior traction caused by vitreous cortex
on the fovea leads to MH formation [28–30]. It is widely
accepted that the genesis of this dynamic force is localized in
the precortical liquiﬁed vitreous pocket, immediately in
front of the macula area, resulting in a passive contraction of
the posterior hyaloid undetached from the fovea [31, 32].
Subsequently, the tangential traction due to the ILM stiﬀ-
ening promotes the progressive MH enlargement.
In contrast, in high myopic eyes, MH formation is re-
lated to more complex pathogenetic mechanisms [33–38]. In
addition to the anteroposterior traction caused by the strong
adhesion of vitreous cortex and to the tangential traction
from the tightening of the ILM, an important role is reserved
to the abnormal growth of myopic eyes that may result in the
development of posterior staphyloma (PS) deﬁned as a
progressive scleral ectasia of the posterior ocular globe wall
(Figure 1(a)) [39].
'e PS introduces new pathogenetic forces in myopic
MH formation and increases the spectrum of tractional
forces in relation to diﬀerent depths and location of the
scleral ectasia with respect to the macular area. 'e cen-
tripetal vector forces are more relevant in case of deeper PS
compared to the ﬂatter staphyloma [40]. Due to the relative
inelasticity of the inner retinal layers and retinal vessels, deep
PS promotes a progressive retinal split which initially results
in the development of a myopic foveoschisis (FS)
(Figure 1(b)) and ﬁnally may lead to a retinal detachment
involving the posterior pole.
In the case of ﬂat PS, vitreoretinal tractions are not
suﬃcient to produce the concomitant FS or retinal de-
tachment [41, 42], and the pathogenetic mechanism of MH
formation seems to be similar to those of emmetropic eyes
[43].
Recently, several mechanisms regarding the develop-
ment of MH in highly myopic patients were analyzed, and
diﬀerent pathways of MH formation were reported [44]. In
detail, a normal foveal depression with abnormal vitreor-
etinal relationship characterized the ﬁrst pathway.
According to the main tractional forces recognized, two
diﬀerent processes can be distinguished. Similar to MH in
emmetropic eyes, in high myopic eyes, the anteroposterior
vitreomacular traction (VMT) induces a vitreomacular
separation with the disruption of the inner laminar layers
and the formation of inner foveal cysts with or without small
foveal detachment (Figure 1(c)). 'e rupture of intraretinal
cysts results in a disruption of outer laminar layers followed
by the progression in a full-thickness MH. Alternatively, the
posterior hyaloid may separate from the fovea, and the
development of a tangential traction exerted from the
surrounding preretinal membrane leads to a lamellar MH
formation.'e progressive foveal disruption results in a full-
thickness MH [44].
A second pathway is characterized by the presence of
FS that may occur with or without macular detachment. FS
is not an uncommon ﬁnding in highly myopic eyes (9–
34%) [43] and is believed to be one of the main causes of
MH formation in these patients [45–47]. A macular schisis
promotes a tangential or multidirectional traction with the
development of lamellar MH. 'e continuous traction
caused by the preretinal membrane induces the evolution
in a full-thickness MH [44]. When macular schisis occurs
with foveal detachment, an outer laminal dehiscence can
be observed (Figure 1(d)). If preretinal traction induces
inner laminar dehiscence, a full-thickness MH may de-
velop with a macular retinal detachment (Figure 1(e))
[44, 48].
Finally, the third pathway includes MH with concom-
itant chorioretinal atrophy or underlying macular scar. Both
progressive retinal thinning over the lesion and tangential
traction promote theMH formation that may occur adjacent
to the margins or within the lesion area [44].
In a recent report, Lai et al. [49] analyzed the lamellar
hole-associated epiretinal proliferation (LHEP) in lamellar
MH and full-thickness MH in high myopic eyes. 'is epi-
retinal proliferation is a noncontractile membrane localized
at the edge of a deep and wide retinal defect. Several OCT
studies have demonstrated the tight connection between the
inner retinal tissue and LHEP [50] characterized by a ho-
mogeneous mound at OCT examination [51]. Two mor-
phological LHEP ﬁndings, typical of highly myopic eyes,
were described: the broad LHEP extension and LHEP-
posterior hyaloid (PH) adhesion. In eyes with high myo-
pia, a broader extension of LHEP (>1.500 μm from the foveal
center) was observed when compared with nonhighly my-
opic patients. Moreover, a greater prevalence of LHEP-PH
adhesion in eyes with high myopia was detected. 'e LHEP-
PH adhesion was described as the growth of the LHEP along
the PH surface when the PH remains attached to themargins
of the MH and to the space between the hole edge and the
hyaloid.
Although several mechanisms of MH formation are
clearly described in the literature, the exact evolution of this
retinal disease in myopic eyes is not always predictable and
rapid changes from a typical conﬁguration to another
pattern may be observed [44].
Figure 1 shows diﬀerent myopic macular hole patterns.
3. Surgical Techniques
Since the introduction of three-port PPV with gas tampo-
nade in the 90s [11, 12], several surgical strategies have been
developed for the MH repair in high myopic eyes, including
silicone oil tamponade, episcleral posterior buckling,
suprachoroidal buckling, and scleral shortening technique
[52–55].
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Figure 1: Diﬀerent myopic macular hole (MH) patterns. (a) Full-thickness MH with intraretinal cysts in deep posterior staphyloma. (b)
Full-thickness MH with perilesional foveoschisis. (c) Vitreomacular separation with vitreofoveal adhesion which causes the dehiscence of
the inner retinal layers and the formation of inner foveal cysts. (d) Vitreomacular traction with impending macular hole associated with
diﬀuse macular schisis and foveal detachment which results in outer retinal layers disruption. Note: the important traction exerted by the
thickened posterior hyaloid undetached from the fovea and the consequential retinal split due to the deep posterior staphyloma. (e)
Complete disruption of the inner and outer retinal layers resulting in macular retinal detachment.
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Although PPV with ILM peeling and intraocular gas
tamponade leads to an anatomical closure rate more than
90% for idiopathic MH [56], in highly myopic eye the
successful closure of MH varies considerably from 60% to
100% and some patients require multiple treatments in order
to achieve the closure of the hole [20, 57]. 'e aim of
vitrectomy is to release all vitreoretinal tractions from the
vitreous and the epiretinal tissue and to reduce macular
stretching caused by the ILM in order to promote retinal
elongation and adaptation to the posterior staphyloma, if
present.
In highly myopic eyes, the ILM appears thin, sticky, and
strongly adhered to the retinal surface; moreover, preretinal
membranes showed a multilayered and heterogeneous as-
pect composed of vitreous cortex residuals, ERM, and ILM
[58]. Because of these features, ILM tends to break into
several little sections rather than peel oﬀ in a sheet during its
surgical removal [59]. 'is aspect may lead to diﬃcult and
dangerous ILM peeling because the subsequent ILM
regrasping is associated with a higher risk of iatrogenic
retinal breaks [60].
To avoid these diﬃculties, several tools have been in-
troduced in vitreoretinal surgery for the treatment of
myopic MH helping the surgeons to perform a safe and
eﬀective procedure. 'e chromovitrectomy helps to better
identify the vitreous and the epiretinal membranes in
myopic eyes. 'e use of triamcinolone acetonide increases
the visualization of the vitreous body and vitreous cortex
that remains tightly adhered to the retina plane in high
myopic patients. Furthermore, the introduction of vital
dyes allows to stain the posterior pole and correctly rec-
ognized the ERM (trypan blue) and the ILM (brilliant blue,
lutein/zeaxanthin + brilliant blue). Moreover, the use of
speciﬁc light ﬁlters can provide a better visualization of
stained ILM in myopic eyes [61], reducing the retina light
toxicity [62].
In order to avoid the inadvertent migration of vital dyes
into the subretinal space, several substances have been used
during the dye-assisted ILM peeling in MH surgery [63–65].
To promote the gentle injections of vital dyes and heavy
liquids into the vitreous cavity and to avoid ﬂuid turbulence,
several devices with a steady and slow jet have been in-
troduced [66]. Speciﬁc dual-bore cannula with a side port for
ﬂuid injection prevents the risk of retinal injury caused by a
ﬂuid jet stream and promotes a faster pressure relief during
injection by multiple ﬂuid egress vents [67].
'e microscope-integrated intraoperative OCT in MH
surgery allows a real-time visualization of the vitreoretinal
interface [68]. 'is device provides an imaging of foveal
architecture during the tissue-instruments interaction
helping the surgeon to release in a safe manner the VMTand
to identify and remove residual ERM or ILM if present [69].
In high myopic MH, several factors may inﬂuence the
anatomical and functional outcomes after surgery [44] in-
cluding the increased axial length, the retinal shortening
over an elongated sclera [57], the presence of posterior
staphyloma [70], the presence of severe traction maculop-
athy [63], the presence of foveoschisis [41], and the intra-
operative peeling of rigid and stiﬀ ILM [71].
'e extension of ILM peeling is a matter of controversy.
For a successful MH closure, no clear guidelines regarding
the minimum area of ILM peeling are available [72]. Due to
the adhesion between the ILM and the retinal nerve ﬁber
layer—ganglion cell layer complex, the peeling maneuver
might damage these inner retinal layers with consequently
poor postoperative visual acuity [73]. 'us, a smaller ILM
peeling might be more respectful of the retinal nerve ﬁber
layer—ganglion cell layer complex [74]. On the other hand, a
wider peeling extended up to the vascular arcades might be
useful in order to reduce the complex tractional forces in the
myopic retina [75].
However, ILM peeling in myopic FS is currently under
debate. Due to thin central foveal tissue, an iatrogenic full-
thickness MH could develop during ILM removal. 'e risk
of this complication ranges from 16.7 to 20.8% [76] and
signiﬁcantly increases in case of outer lamellar macular hole
[77]. To reduce the risk of this complication and to preserve
the epifoveal ILM, foveal-sparing ILM peeling procedures
were introduced [76–79]. Although these techniques have
showed a better success rate and visual outcome when
compared to the classic ILM peeling, no consensus regarding
the ILM area to be preserve was developed. A range from 300
to 1000 μm diameter was reported in diﬀerent studies [77].
Anatomical results showed the primary success rate limited
to 50–73.3% with vitrectomy, ILM peeling, and gas tam-
ponade in high myopic eyes [80].
Recently, for persistent myopic MH, the inverted ILM
ﬂap technique was introduced [81]. In this procedure, the
remnant of an incomplete ILM peeling is left and then
inverted inside themacular hole to provide a scaﬀold forMH
closure [81]. At the beginning, many surgeons believed
necessary to insert the ﬂap into the hole like a plug. Now it is
thought suﬃcient to cover the hole with the peeled ILM ﬂap
in order to obtain a division between the vitreous cavity and
the intraretinal spaces and to promote the MH repair
mechanism [82]. 'e original procedure consisted of cir-
cumferentially 2-disc-diameter ILM peeling around the MH
to preserve the adhesion between the inner ILM outline and
the MH edges. Afterwards, the ILM ﬂap was folded and
gently positioned inside the MH [81]. For ILM ﬂap ma-
nipulation and positioning, diﬀerent techniques have been
described to prevent the ﬂap dislocation during the ﬂuid-air
exchange or in the postoperative period. 'ese strategies
include the use of viscoelastic [83] or perﬂuorocarbon [84]
before balanced saline solution-air exchange, ﬂuid-air ex-
change with low intraocular pressure and passive aspiration
[75], and the addition of autologous serum [14, 22] or
platelet-rich plasma [85]. Platelet-rich plasma seems to
achieve better anatomical results compared to the autolo-
gous serum due to its greater adhesiveness to the edges of the
hole [82].
In order to increase the ILM ﬂap maneuverability and to
reduce its displacement, several studies suggested the use of a
bigger ILM ﬂap which is resized and trimmed using the
vitrectomy probe and subsequently plugged into the hole
[20, 75, 86]. If ERM is present, it may be inverted with the
ILM into the hole [20]. To avoid macular hole packing with a
folded multilayered ILM, the creation of a single-layer
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inverted ﬂap was suggested [84]. 'is large monolayer ILM
ﬂap seemed to promote regular glial cells proliferation and to
create a physiological scaﬀold for the photoreceptors
[84, 87]. To preserve the nasal maculopapillary nerve ﬁber
layer, a 270-degree C-shaped temporal ILM ﬂap has been
suggested [23]. ILM ﬂap is peeled towards the hole but
stopped approximately 0.5 disc diameter from the center of
the fovea, and a single smooth layer is used to cover the MH.
'is technique provides a reduction in dissociated optic
nerve ﬁber layer [88] and is able to release more than 180°
traction from the temporal side. A surgical variant of 180°
superior ILM ﬂap which does not require postoperatively
prone positioning was also proposed [89].
'e inverted ILM ﬂap approach remains technically
challenging even for an experienced surgeon [90]. To further
steady the ﬂap in an adequate position, the vitreous cavity
can be ﬁlled with gas or silicone oil [20, 26, 75]. Compared to
gas, silicone oil is characterized by long-lasting but weaker
tamponade action, especially for myopic eyes with deep
posterior staphyloma because of its diﬃculty to ﬁt into this
area. Nevertheless, silicone oil has been tested as a tam-
ponade in highly myopic eyes, and it surprisingly demon-
strated to be an eﬀective tamponade for the treatment of MH
[53]. It has been demonstrated that silicone oil creates a
bursa inside the MH with a compartmentalization of che-
motactic and nutrient substances. 'ese substances might
promote reparative mechanism which supports the closure
of the hole [82].
Although the anatomic success of inverted ILM ﬂap
technique without retinal detachment range from 94% to
100% [75, 81], a previous PPV with complete ILM peeling
precludes the feasibility of this surgical approach in case of
MH reopening. In these cases, several alternatives have been
described including the use of anterior and posterior lens
capsular ﬂap transplantation [91] or the autologous trans-
plantation of the ILM [25]. Recently, autologous neuro-
sensory retinal free ﬂap transplantation (ANRFF) technique
with gas or silicone oil tamponade was introduced [92, 93].
Chen et al. [91] described the use of anterior and posterior
capsule lens to close refractory MH, due to its similar nature
to ILM, reporting a signiﬁcantly better closure rate with the
anterior capsule ﬂap but not a signiﬁcantly VA improvement
than eyes treated with the posterior one. Once obtained a
circular anterior or posterior capsular ﬂap, it is stained with
0.125% ICG and transplanted into the hole [91]. 'e ad-
vantages of a lens capsular ﬂap are its higher density
compared with ILM making it easier to settle down on the
retinal surface and its easy feasibility.
Autologous transplantation of the ILM was ﬁrst de-
scribed by Morizane et al. [25]. 'is surgical approach
consists of visualization of residual ILM using 0.25mg/mL
brilliant blue G solution and creation and transplantation
of a free ﬂap of ILM inside the macular hole. Grewal and
Mahmoud [92] described the use of ANRFF trans-
plantation for refractory myopic MH complicated by ret-
inal detachment. 'is technique involves harvesting an
autologous neurosensory retinal free ﬂap and gently po-
sitioning it over the refractory MH using bimanual ap-
proach [92].
In highly myopic eyes, a macular hole with retinal de-
tachment (MHRD) can occur. Vitrectomy with removal of
cortical vitreous and ILM and gas or silicone oil tamponade
has become the standard of care for MHRD treatment [94].
Although anatomic reattachment can be achieved, the
success rate ofMH closure ranges from 50% to 70% and poor
postoperatively visual acuity was reported [23, 95, 96]. 'e
inverted ILM ﬂap technique has been demonstrated to be a
useful strategy to increase the closure rate of the hole in
MHRD [20, 22, 23]. Macular buckling has also been in-
troduced as a treatment option for both primaryMHRD and
MHRD refractory to vitrectomy with an anatomical success
rate ranging from 70% to 100% [97–101]. 'is technique
aims to reduce the complex anteroposterior and tangential
tractions resulting from PS in highly myopic eyes through
the modiﬁcation of macular shape from concave to convex
proﬁle. According to the intraoperative diﬃculty to check
the correct position of the buckle and to place sutures
posteriorly, several buckles with diﬀerent designs and ma-
terial have been described [102–104].
Considering that eyes with extremely high myopia can
frequently exceed 30mm in the axial length, surgical in-
strumentation, such as vitreous forceps, must be evaluated
accurately during PPV. To overcome the inability to reach
the retinal surface, surgeons can verticalize the instruments
and carefully apply a pressure on the sclera wall in order to
temporarily reduce the axial length of the globe [105].
However, these maneuvers are not free from complications,
such as limited visibility due to erroneous contact and
dislocation of the viewing system, corneal folds and im-
paired surgeon maneuverability which result in a longer
operation time and challenging surgical procedures [106]. To
prevent complications resulting from iatrogenic trauma,
long-shaft forceps for ILM peeling speciﬁc for highly myopic
eyes were developed [107]. Curved elongated instruments
were also proposed [105].
Microincision vitrectomy surgery (MIVS) has potential
advantages compared to conventional vitrectomy in highly
myopic eyes. Despite the lowest incidence of complications
with the small-gauge system compared to conventional
vitrectomy, no statistically signiﬁcant diﬀerence in visual
outcomes has been reported [59]. With MIVS a small-
diameter sutureless sclerotomies may be performed. 'is
surgery is characterized by a faster postoperative recovery,
less postoperative inﬂammation and patient discomfort, and
reduction of iatrogenic peripheral breaks incidence
[108, 109]. However, in some cases, the self-healing scle-
rotomies can remain open with spontaneous leakage and
early postoperative hypotony. 'is condition mainly occurs
in myopic patients due to the anatomical characteristic of
these eyes with a thinner sclera and a deranged ﬁbrillar
architecture [110].
'e intrascleral tunnel morphology plays a key role in
avoiding the sclerotomy leakage. Both biplanar oblique-
perpendicular-bevel-down trocar insertion and longer
tunnel have a lower incidence of early hypotony when
compared to straight bevel-up and shorter sclerotomies
[111–114]. To promote the wound sealing, several options
have been introduced, including the prolonged sclerotomy
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massage [115, 116], transconjunctival and trans-scleral ab-
sorbable suture [117], releasable sutures [118], use of ﬁbrin
glue or polyethylene glycol hydrogel polymer [119, 120], and
conjunctival cauterization [117]. 'e introduction of 27-
gauge vitrectomy with scleral incision diameter of 0.4mm
does not require biplanar trocar insertion, thus reducing the
risk of postoperative hypotony in myopic eyes [121, 122].
4. Conclusions
Several and complex tractional mechanisms are implicated
in the development of MH in myopic eyes including the
anteroposterior forces due to the strong adhesion of vitreous
cortex, the tangential traction on the macula caused by the
ILM, as well as the centripetal vector forces exerted by the
PS. Related to these anatomical conditions, myopic eyes still
remain a challenge for vitreoretinal surgeons. In the last
decades, the introduction of signiﬁcant innovations for the
treatment of myopic MH has allowed vitreoretinal surgeons
to perform a safe and eﬀective surgery in these complicated
eyes.
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